Clinical Trial Update: Outcomes of Opioid Addicted Prisoners With Extended-Release Injectable Naltrexone [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update reporting outcomes for extended-release injectable naltrexone in opioid-dependent prisoners, across Phase 2 and Phase 3, with results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opiate Dependence

Drugs mentioned

• extended-release injectable naltrexone (naltrexone (extended-release injectable))

Snippet

Sponsor: University of Pennsylvania | Conditions: Opiate Dependence | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2020-04-15